中国药业2026，Vol.35Issue(6)：18-21,4.DOI:10.3969/j.issn.1006-4931.2026.06.004
2023年广州市化妆品生产许可现场检查问题分析与监管对策研究
Analysis of Issues in On-Site Inspections for Cosmetic Production Licensing in Guangzhou in 2023 and Research on Regulatory Countermeasures
摘要
Abstract
Objective To provide a basis for improvement the on-site inspections work for cosmetic production licensing for both enterprises and regulatory authorities.Methods The on-site inspection data for production licensing of 617 cosmetic manufacturing enterprises in Guangzhou in 2023 were statistically analyzed.Referring to the Key Points for Inspection and Principles for Determination for Cosmetic Production Quality Management Standards″,issues were categorized and sorted out according to the level of defective items(critical items,key items,general items).The main problems and risk points in the production process were analyzed based on specific clauses and manifestations.Results A total of 286 enterprises(46.35%)failed the on-site inspections.The defective clauses were primarily concentrated in key items(2 340 times,56.60%)and general items(1 581 times,38.24%).Although critical items accounted for a low proportion(213 times,5.15%),the risks were severe and required attention.The main issues leading to inspection failure included defects in raw material compliance,lack of control in production process management,insufficient implementation of the quality management system,and non-standard material management.Conclusion Cosmetic manufacturing enterprises in Guangzhou need to strengthen the construction of their quality management systems,optimize production process control,and enhance hardware facility and environmental controls.Regulatory authorities should carry out precise hierarchical and classified supervision,improve the communication and implementation of regulations,and promote co-governance with industry associations,collectively working to enhance industry standardization and safety.关键词
化妆品生产/广州市/现场检查/质量管理Key words
cosmetic production/Guangzhou/on-site inspection/quality management分类
医药卫生引用本文复制引用
何羡霞,姜志辉,胡树文,赵伟..2023年广州市化妆品生产许可现场检查问题分析与监管对策研究[J].中国药业,2026,35(6):18-21,4.基金项目
广东省广州市科技计划项目[2024A03J0644]. （）
